Key result
Drug-eluting stents, including sirolimus- and paclitaxel-eluting stents, are emerging as a potential strategy to prevent in-stent restenosis, with ongoing trials evaluating their safety and efficacy.
Why the study?
Do drug-eluting stents prevent in-stent restenosis in patients undergoing coronary stent implantation?
Do drug-eluting stents prevent in-stent restenosis in patients undergoing coronary stent implantation?
Answers are grounded in this paper and cite their sources.
Drug-eluting stents represent a promising strategy to prevent in-stent restenosis, with ongoing evaluation in complex lesion subsets.
Despite the success of coronary stent implantations in the last decade, in-stent restenosis due to neointimal hyperplasia remains a problem to overcome. Neointimal hyperplasia is a vascular response to stent injury and mainly consists of proliferation of smooth muscle cells and deposition of extracellular matrix. Recently, local drug delivery has been advocated as a potential strategy to prevent in-stent restenosis. Unprecedented results have been obtained in early clinical studies on sirolimus-eluting and paclitaxel-eluting stents. Trials using various pharmaceutical coatings on different coronary stents are ongoing. More types of drug-eluting stents are expected on the market in the near future. Meanwhile, the evaluation of drug-eluting stents is entering the second phase in which the safety and efficacy in more complex lesion subsets and different clinical presentations are being investigated. Results including cost-benefit analyses are expected to have a tremendous impact on the practice of interventional cardiology in the next decade.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2006) conducted a review in In-stent restenosis. Drug-eluting stents (sirolimus-eluting and paclitaxel-eluting stents) was evaluated. Drug-eluting stents, including sirolimus- and paclitaxel-eluting stents, are emerging as a potential strategy to prevent in-stent restenosis, with ongoing trials evaluating their safety and efficacy.
Synapse has enriched 10 related papers. Consider them for comparative context: